Period Ending | Period | Revenue ($m) | Pre-tax ($m) | EPS | Dividend |
---|---|---|---|---|---|
30-Jun-24 | Interim | 2,820.00 | (961.70) | 2.50¢ | n/a |
Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-19 | 9,890.40 | 148.70 | 47.10¢ | 10.7 | 10.7 | +1% | 11.40¢ | 2.3% |
31-Dec-20 | 7,564.30 | (148.60) | 23.20¢ | 16.8 | n/a | -51% | n/a | 0.0% |
31-Dec-21 | 5,212.30 | (172.00) | 2.10¢ | 114.6 | n/a | -91% | n/a | 0.0% |
31-Dec-22 | 5,461.30 | (691.40) | 2.30¢ | 74.0 | 7.4 | +10% | n/a | 0.0% |
31-Dec-23 | 5,900.70 | (62.70) | 2.30¢ | 94.2 | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-24 | 5,877.79 | 221.09 | 5.72p | 9.5 | 0.0 | +214% | n/a | 0.0% |
31-Dec-25 | 6,135.10 | 272.06 | 10.41p | 5.2 | 0.1 | +82% | 0.62p | 0.0% |
31-Dec-26 | 6,396.81 | 300.59 | 13.67p | 4.0 | 0.1 | +31% | 2.78p | 0.0% |
Copyright © 2024 FactSet Research Systems Inc. All rights reserved.
5 Yr High | 5 Yr Low | 5 Yr Avg | Curr / Avg | |
---|---|---|---|---|
Latest | 11.22 | 11.22 | 63.79 | 0.46 |
Find out about IFRS and how this affects the financial infomation for all UK companies.
Currency | UK Pounds |
Share Price | 54.15p |
Change Today | 2.60p |
% Change | 5.04 % |
52 Week High | 210.20 |
52 Week Low | 49.66 |
Volume | 8,773,178 |
Shares Issued | 691.84m |
Market Cap | £374.63m |
Beta | 2.19 |
RiskGrade | 236 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 5 |
Buy | 0 |
Neutral | 2 |
Sell | 0 |
Strong Sell | 0 |
Total | 7 |
Latest | Previous | |
---|---|---|
Interim | Final | |
Ex-Div | 29-Aug-19 | 25-Apr-19 |
Paid | 26-Sep-19 | 16-May-19 |
Amount | 11.40¢ | 23.70¢ |
Time | Volume / Share Price |
15:35 | 155 @ 54.05p |
16:40 | 691,635 @ 51.54p |
16:35 | 3,363 @ 54.15p |
16:29 | 37 @ 54.15p |
16:29 | 5,000 @ 54.19p |
Chair | Roy Franklin |
CEO | Ken Gilmartin |
CFO | Arvind Balan |
You are here: research